B cell defects in SLP65/BLNK-deficient m
✍
Judith Gerlach; Snigdha Ghosh; Hassan Jumaa; Michael Reth; Jürgen Wienands; Andr
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 319 KB
CD22 is an inhibitory coreceptor for B cell receptor (BCR) signaling. The inhibition is most likely mediated by activation of SHP-1. We found that SLP65/BLNK reaches maximal tyrosine-phosphorylation at earlier time points in CD22(-/-) than in wild type B cells upon BCR cross-linking, suggesting that